自膨式支架市場：現況分析與預測（2023-2030）

Self-Expandable Stents Market: Current Analysis and Forecast (2023-2030)

出版日期: 2024年03月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 132 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

自膨脹支架是用於治療血管狹窄或閉塞的醫療器械，主要應用於介入性心臟病學和血管外科領域。與必須充氣才能擴張的球囊擴張支架不同，自擴張支架設計為一旦插入血管就會自動擴張。這一特性使其在血管移動或直徑變化的區域特別有用。週邊動脈疾病（PAD）和冠狀動脈疾病（CAD）等心血管疾病的盛行率不斷上升，刺激了對支架置入等介入治療的需求，從而促進了市場擴張。例如，根據疾病管制與預防中心的數據，60% 的美國人患有至少一種慢性疾病，如心臟病、糖尿病或癌症。此外，據報道，2021年美國將有約65萬人死於心臟病。

2022 年自膨式支架市值為 32 億美元，預估 2023 年至 2030 年複合年增長率約為 7.5%。

產品分為頸動脈自膨式支架、胃腸自膨式支架、血管內支架等。頸動脈自膨式支架細分市場在2022年佔據最大的市場。頸動脈狹窄等冠狀動脈疾病發生率的增加是市場的主要驅動因素之一。

依應用，市場分為股動脈、髂動脈、頸動脈、膽動脈等。其中，頸動脈應用出現了顯著增長，這主要是由於越來越多地採用頸動脈支架置放術（CAS）作為頸動脈疾病的治療選擇。

依最終用戶劃分，市場分為醫院、門診手術中心等。其中，門診手術中心出現快速增長，主要是由於門診手術中心在不同地區的大量存在以及越來越多的患者選擇門診手術中心進行支架置入相關手術所致。

為了更瞭解該產業的市場採用情況，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、義大利、西班牙、歐洲其他地區）、亞洲太平洋地區（中國、日本、印度、韓國、澳洲和亞太地區其他地區）以及世界其他地區。到2022年，北美將在自膨式支架市場中佔據壓倒性佔有率。北美完善的醫療基礎設施、不斷上漲的醫療成本以及不斷增加的心血管疾病患者數量是推動北美市場成長的主要因素。

市場上營運的主要公司包括Boston Scientific Corporation、Medtronic、Cordis、Cook Medical、Biotronik, Inc.、Abbott、BD Interventional、Merit Medical Systems, Inc.、Terumo Corporation、Veryan Medical。

Self-expandable stents are medical devices used primarily in the field of interventional cardiology and vascular surgery to treat narrowed or blocked blood vessels. Unlike balloon-expandable stents that require inflation to deploy, self-expandable stents are designed to expand automatically upon insertion into the targeted vessel. This property makes them particularly useful in regions of the body where vessels are subject to movement or variation in diameter. The rising incidence of cardiovascular disorders, such as PAD and CAD, fuel the demand for interventional therapies like stent implantation, contributing to market expansion. For instance, as per the data of Certers for Disease Control and Prevention, 60% of the Amaercans are living with atleast one of the chronic disorder like heart disease, diabetes, or cancer. Further, about 650,000 deaths related to heart diasese were reported in United States during year 2021.

The Self-expandable Stents Market was valued at USD 3,200 Million in 2022 and is expected to grow at a CAGR of around 7.5% from 2023-2030.

Based on the product, the market is segmented into Carotid Self-expanding Stents, Gastrointestinal Self-expanding Stents, Endovascular Self-expandable Stents, and Others. The carotid self-expanding stents segment held the largest market share in 2022. Rising incidence of coronary artery disorders such as carotid artery stenosis etc. is acting as one of the major driver for the market.

On the basis of application, the market is categorized into Fem-Pop Artery, iliac Artery, Carotid Artery, Biliary, and Other. Among these, significant growth is observed in the carotid artery application which is mainly due to increasing adoption of carotid artery stenting (CAS) as an treatment option for carotid artery disease.

On the basis of end user, the market is categorized into Hospitals, Ambulatory Surgical Centers, and Others. Among these, exponential growth is observed in the ambulatory surgical centers which is mainly due to substantial presence of ambulatory surgical centers in various geographies and increasing preference of patients towards the ambulatory surgical centers for stenting related procedures.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of Self-expandable Stents Market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure and rising cases of cardiovascular disorders in the countries is the major attributing factor for the market growth in North America.

Some of the major players operating in the market include Boston Scientific Corporation, Medtronic, Cordis, Cook Medical, Biotronik, Inc., Abbott, BD Interventional, Merit Medical Systems, Inc., Terumo Corporation, and Veryan Medical.

1.MARKET INTRODUCTION

1.1.Market Definitions
1.2.Main Objective
1.3.Stakeholders
1.4.Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

2.1.Research Process of the Self-expandable Stents Market
2.2.Research Methodology of the Self-expandable Stents Market
2.3.Respondent Profile

3.MARKET SYNOPSIS

4.EXECUTIVE SUMMARY

5.GLOBAL + COVID-19 IMPACT

6.GLOBAL SELF-EXPANDABLE STENTS MARKET REVENUE, 2020-2030F

7.MARKET INSIGHTS BY PRODUCT

7.1.Carotid Self-expanding Stents
7.2.Gastrointestinal Self-expanding Stents
7.3.Endovascular Self-expandable Stents
7.4.Others

8.MARKET INSIGHTS BY APPLICATION

8.1.Fem-Pop Artery
8.2.Iliac Artery
8.3.Carotid Artery
8.4.Biliary
8.5.Other

9.MARKET INSIGHTS BY END USER

9.1.Hospitals
9.2.Ambulatory Surgical Centers
9.3.Others

10.MARKET INSIGHTS BY REGION

10.1.North America Self-expandable Stents Market
- 10.1.1.U.S.
- 10.1.2.Canada
- 10.1.3.Rest of North America
10.2.Europe Self-expandable Stents Market
- 10.2.1.Germany
- 10.2.2.UK
- 10.2.3.France
- 10.2.4.Italy
- 10.2.5.Spain
- 10.2.6.Rest of Europe
10.3.Asia-Pacific Self-expandable Stents Market
- 10.3.1.China
- 10.3.2.Japan
- 10.3.3.India
- 10.3.4.Rest of APAC
10.4.Rest of the World Self-expandable Stents Market